Vital Therapies reported $-20116000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Biomarin Pharmaceutical BMRN:US USD 2.38M 36.77M
Enanta Pharmaceuticals ENTA:US USD -27048000 5.49M
Insmed INSM:US USD -122459000 21.52M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Omeros OMER:US USD -50766000 13.33M
Orasure Technologies OSUR:US USD 7.43M 18.18M
Regulus Therapeutics RGLS:US USD -7563000 388K
Revance Therapeutics RVNC:US USD -77484000 19.64M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
United Therapeutics UTHR:US USD 314.3M 112.5M
Vital Therapies VTL:US USD -20116000 494K
Xoma XOMA:US USD -4372000 395K